Employer-sponsored health insurance premiums are projected to see their largest single-year increase in 20 years in 2027, rising 11% and approaching a nearly four-fold increase since the start of the century. The rising costs are affecting workers and healthcare professionals alike, with some providers going without coverage.
Blue Cross Blue Shield Association released a study claiming AI-backed billing tools used by healthcare providers have generated nearly $1 billion in additional costs over two years by enabling more severe patient care coding. The companies making these AI tools dispute the findings, arguing the problem lies with the healthcare billing system itself rather than the technology.
A new CDC report reveals that approximately 71.5% of adults in the United States experienced fatigue on multiple days, with contributing factors including healthcare costs, economic uncertainties, and anxieties about emerging technologies like AI.
The CEO of Swiss pharmaceutical company Sandoz cautioned that President Donald Trump's threatened tariffs on generic drugs would ultimately be paid by American patients, as manufacturers could pass increased costs onto consumers.
The CEO of Swiss pharmaceutical company Sandoz cautioned that President Donald Trump's threatened tariffs on generic drugs would ultimately be paid by American patients, as manufacturers could pass increased costs onto consumers.
Hims & Hers Health reported a wider-than-expected second-quarter loss as the telehealth company's shift to branded weight-loss drugs drove up costs, sending shares down 6% in extended trading. The company plans to enter the peptides market before year-end.
CVS Health exceeded second-quarter earnings and revenue estimates and raised its full-year guidance, driven by better-than-expected medical costs in its Aetna insurance business. The results signal improvement in the struggling insurance division.
Americans are expected to spend more than $1 trillion on prescription drugs in 2026, according to a new report from the American Society of Health-System Pharmacists. The surge is largely attributed to the growing popularity of GLP-1 weight-loss drugs.
A Harvard-backed study found that the Inflation Reduction Act's drug provisions are helping Medicare beneficiaries stay on their medications. However, the reforms have not yet reduced overall healthcare costs or financial anxiety for beneficiaries.
Health insurance premiums for Affordable Care Act marketplace plans are projected to rise by a median of 14% in 2027 according to preliminary insurer filings analyzed by KFF, marking the second straight year of double-digit increases and creating significant cost pressures for middle-income Americans.
